Medi Assist Q1 FY27: Growth holds up as integration nears closure and tech monetisation begins

Medi Assist Healthcare Services Limited entered FY27 with a strong start on the income statement, while continuing to work through the operational and margin after-effects of the Paramount acquisition. In Q1 FY27, consolidated total income rose to 247.0 crore, up 24.9% year on year. Operating revenue was 236.5 crore, up 24.1% year on year. EBITDA grew 14.3% to 48.0 crore, and reported PAT rose 21.9% to 27.6 crore.

Margins, however, remained the key debate. EBITDA margin for the quarter stood at 20.3%, down 175 bps versus Q1 FY26, but up 40 bps sequentially versus Q4 FY26. Management positioned this as a continuing recovery from the integration-driven trough seen in Q2 FY26, and reiterated that Paramount integration is close to completion.

Core India TPA still drives the P and L

The segment mix continues to be dominated by the Group business, which contributed 166.0 crore of revenue, or 70.2% of operating revenue. The segment grew 25.5% year on year, supported by premiums administered of 8,454 crore, up 29.5%. Management also reported a Group market share of 37.6% and Group PUM retention of 90.2%.

Retail remains a more nuanced story because the company now reports both a TPA model and a platform or hybrid model. In the reported retail TPA model, Q1 FY27 revenue was 23.4 crore, up 13.1% year on year. But premiums managed in the TPA model fell 5.0% year on year to 521 crore. Management explained on the call that retail participation is increasingly happening through integrations where Medi Assist runs back-end servicing and technology, even when the insurer remains the primary customer interface.

Government operations delivered the fastest growth among the larger domestic segments. Q1 FY27 government revenue was 28.5 crore, up 35.3% year on year, contributing 12.0% of operating revenue. Management highlighted that it services around 31 crore members across 12 states and 4 union territories.

A key profitability nuance in the quarter was the one-time derivative gain linked to the acquisition of non-controlling interest in Mayfair, which added 3.1 crore to PAT. The company disclosed an adjusted PAT of 24.5 crore excluding that benefit.

Paramount integration and the margin recovery arc

The EBITDA margin bridge in the investor presentation framed Q1 FY27 as part of a steady climb after the post-acquisition impact. The company highlighted that margins improved from 17.1% in Q2 FY26 to 20.3% in Q1 FY27, a 320 bps recovery.

On operations, management stated that Paramount integration is at what it called a logical closure. Migration progress to the Medi Assist stack is central to this claim. By the end of Q1 FY27, over 95% of group claims and over 80% of retail claims volumes from Paramount Healthcare Services had been migrated to MMatrix. The company targets 100% migration by Q2 FY27.

This matters because the company is linking the integration timeline directly to a return to historical margins. In the Q and A, management stated that the immediate priority is to finish the remaining activities in the Paramount integration and work back toward historical EBITDA levels of around 22% to 23% toward the end of FY27.

Balance sheet commentary was also supportive of this stance. Medi Assist reported a zero-debt position and a free cash position of 245.5 crore as of the quarter-end. Net worth stood at 884.1 crore, and contract liabilities were 337.4 crore.

Tech platform momentum becomes more visible

Technology revenue in Q1 FY27 rose 55.5% year on year to 7.8 crore, contributing 3.3% of operating revenue. While still small in the consolidated mix, management used the quarter to position the tech business as a standalone growth engine. The company stated that its stack is now generally available, covering MAtrix for claims processing, Maven Guard for fraud, waste and abuse decisioning, Maven IDP for intelligent document processing, Magnum for provider-side capabilities, and NaaS for network access as a plug-in.

Operational metrics were used to show scale. The company reported that around 32 lakh claims have been processed on Matrix, including about 45k global claims. It also disclosed Maven Guard preventing around 183 crore of fraud in the quarter and said more than 186k pre-authorisations were processed within five minutes.

Commercially, management disclosed that seven insurers are contracted across combinations of Maven, Matrix and Magnum stacks. It also stated that the first outcomes-based contract has been signed, where compensation is tied to fraud, waste and abuse outcomes. The call also included an explicit disclosure on AI investments, with management stating it spent about 24.5 crore over the last six quarters on a board-approved AI roadmap.

International business: soft quarter, bigger platform ambition

The international segment, operated through Mayfair, reported Q1 FY27 revenue of 10.1 crore, down 5.2% year on year, but its contribution increased to 4.3% of operating revenue. Management attributed the softness to external demand factors rather than client losses, citing a decline in leisure travellers and a larger decline in students going abroad.

Strategically, the company strengthened control over the platform by increasing its stake in Mayfair to 91.75% post Q1. It also highlighted that the first international technology deployment contract went live in Thailand effective July 1, 2026, positioning this as a reference deployment for the region.

Governance and operating cadence

Beyond the operating performance, the earnings call included a governance update. Management stated that Dr. Vikram Chhatwal will transition from Executive Chairman to a Non-Executive, Non-Independent Chairman, subject to shareholder approval at the AGM scheduled for September 8. The stated rationale was aligning with best practice by separating board leadership from executive management.

Takeaways for investors

Medi Assist delivered strong top-line growth in Q1 FY27, with sequential margin improvement and a continued recovery path from integration impacts. The key near-term execution variable remains the final phase of Paramount migration, which management has tied to a return toward historical EBITDA margins by the end of FY27.

At the same time, the quarter provided clearer evidence that the company is building a second business layer beyond the traditional TPA model. Technology revenue is growing quickly, insurer contracting has expanded to seven relationships, and the company has begun disclosing outcomes-based monetisation models. International performance was weak in the quarter, but the increased stake in Mayfair and the Thailand go-live indicate that the company is attempting to productise its India-built stack for overseas use cases.